Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-151998
Filing Date
2022-05-16
Accepted
2022-05-16 17:13:37
Documents
46
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d288120d10q.htm   iXBRL 10-Q 617100
2 EX-31.1 d288120dex311.htm EX-31.1 10717
3 EX-31.2 d288120dex312.htm EX-31.2 10705
4 EX-32.1 d288120dex321.htm EX-32.1 3894
5 EX-32.2 d288120dex322.htm EX-32.2 3882
  Complete submission text file 0001193125-22-151998.txt   3206346

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dnac-20220331.xsd EX-101.SCH 35184
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dnac-20220331_cal.xml EX-101.CAL 15496
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dnac-20220331_def.xml EX-101.DEF 182823
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dnac-20220331_lab.xml EX-101.LAB 221220
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dnac-20220331_pre.xml EX-101.PRE 218678
40 EXTRACTED XBRL INSTANCE DOCUMENT d288120d10q_htm.xml XML 360352
Mailing Address 2850 W. HORIZON RIDGE PARKWAY SUITE 200 HENDERSON NV 89052
Business Address 2850 W. HORIZON RIDGE PARKWAY SUITE 200 HENDERSON NV 89052 (650) 521-9007
Social Capital Suvretta Holdings Corp. III (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40560 | Film No.: 22930840
SIC: 2836 Biological Products, (No Diagnostic Substances)